Differential time- and NADPH-dependent inhibition of CYP2C19 by enantiomers of fluoxetine. | Drug Metab Dispos;37(4): 695-8, 2009 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Differential time- and NADPH-dependent inhibition of CYP2C19 by enantiomers of fluoxetine.

Stresser, David M; Mason, Andrew K; Perloff, Elke S; Ho, Thuy; Crespi, Charles L; Dandeneau, Andre A; Morgan, Ling; Dehal, Shangara S.

Affiliation

Stresser DM; BD Biosciences, BD Gentest Contract Research Services, 6 Henshaw Street, Woburn, MA 01801, USA. David_Stresser@bd.com

Drug Metab Dispos ; 37(4): 695-8, 2009 Apr.

Article in En | MEDLINE | ID: mdl-19144769

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aryl Hydrocarbon Hydroxylases / Fluoxetine / Selective Serotonin Reuptake Inhibitors / NADP Limits: Humans Language: En Journal: Drug Metab Dispos Journal subject: FARMACOLOGIA Year: 2009 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aryl Hydrocarbon Hydroxylases / Fluoxetine / Selective Serotonin Reuptake Inhibitors / NADP Limits: Humans Language: En Journal: Drug Metab Dispos Journal subject: FARMACOLOGIA Year: 2009 Document type: Article Affiliation country: Country of publication: